rs62638631

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001034853.2(RPGR):​c.141T>G​(p.Ser47Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000425 in 1,204,786 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 162 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., 15 hem., cov: 23)
Exomes 𝑓: 0.00043 ( 0 hom. 147 hem. )

Consequence

RPGR
NM_001034853.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.471

Publications

1 publications found
Variant links:
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
RPGR Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 3
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • RPGR-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • primary ciliary dyskinesia-retinitis pigmentosa syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • macular degeneration, X-linked atrophic
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-38323412-A-C is Benign according to our data. Variant chrX-38323412-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 98741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.471 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00043 (470/1092373) while in subpopulation MID AF = 0.00927 (38/4099). AF 95% confidence interval is 0.00694. There are 0 homozygotes in GnomAdExome4. There are 147 alleles in the male GnomAdExome4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High AC in GnomAd4 at 42 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRNM_001034853.2 linkc.141T>G p.Ser47Ser synonymous_variant Exon 2 of 15 ENST00000645032.1 NP_001030025.1 Q92834-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRENST00000645032.1 linkc.141T>G p.Ser47Ser synonymous_variant Exon 2 of 15 NM_001034853.2 ENSP00000495537.1 Q92834-6
ENSG00000250349ENST00000465127.1 linkc.172-342709A>C intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.000374
AC:
42
AN:
112359
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000971
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00123
Gnomad ASJ
AF:
0.00264
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000365
Gnomad FIN
AF:
0.000164
Gnomad MID
AF:
0.00420
Gnomad NFE
AF:
0.000300
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000514
AC:
92
AN:
178920
AF XY:
0.000487
show subpopulations
Gnomad AFR exome
AF:
0.0000773
Gnomad AMR exome
AF:
0.000478
Gnomad ASJ exome
AF:
0.00352
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000632
Gnomad NFE exome
AF:
0.000594
Gnomad OTH exome
AF:
0.000674
GnomAD4 exome
AF:
0.000430
AC:
470
AN:
1092373
Hom.:
0
Cov.:
28
AF XY:
0.000411
AC XY:
147
AN XY:
358095
show subpopulations
African (AFR)
AF:
0.000570
AC:
15
AN:
26295
American (AMR)
AF:
0.000569
AC:
20
AN:
35130
Ashkenazi Jewish (ASJ)
AF:
0.00321
AC:
62
AN:
19302
East Asian (EAS)
AF:
0.0000332
AC:
1
AN:
30117
South Asian (SAS)
AF:
0.000112
AC:
6
AN:
53765
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40463
Middle Eastern (MID)
AF:
0.00927
AC:
38
AN:
4099
European-Non Finnish (NFE)
AF:
0.000324
AC:
271
AN:
837313
Other (OTH)
AF:
0.00120
AC:
55
AN:
45889
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000374
AC:
42
AN:
112413
Hom.:
0
Cov.:
23
AF XY:
0.000434
AC XY:
15
AN XY:
34559
show subpopulations
African (AFR)
AF:
0.0000969
AC:
3
AN:
30958
American (AMR)
AF:
0.00122
AC:
13
AN:
10620
Ashkenazi Jewish (ASJ)
AF:
0.00264
AC:
7
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3611
South Asian (SAS)
AF:
0.000366
AC:
1
AN:
2733
European-Finnish (FIN)
AF:
0.000164
AC:
1
AN:
6112
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.000300
AC:
16
AN:
53295
Other (OTH)
AF:
0.00
AC:
0
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000781
Hom.:
3
Bravo
AF:
0.000359

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 27, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 07, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser47Ser in exon 2 of RPGR: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 0.1% (47/34663) of E uropean chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broad institute.org; dbSNP rs62638631). -

Sep 27, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RPGR: BP4, BS2 -

Primary ciliary dyskinesia Benign:2
Mar 25, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
2.8
DANN
Benign
0.61
PhyloP100
0.47
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62638631; hg19: chrX-38182665; API